T1	Participants 141 185	women with suspected coronary artery disease
T2	Participants 235 278	Ischemia Evaluation in Women (WOMEN) trial.
T3	Participants 418 433	remains unclear
T4	Participants 446 575	addition of myocardial perfusion imaging (MPI) to the standard ECG exercise treadmill test (ETT) provides incremental information
T5	Participants 664 692	randomized symptomatic women
T6	Participants 878 948	2-year incidence of major adverse cardiac events, defined as CAD death
T7	Participants 1028 1037	824 women
T8	Participants 1309 1373	2 years, there was no difference in major adverse cardiac events
